Kidney outcomes associated with use of SGLT2 inhibitors in real-world clinical practice (CVD-REAL 3): A multinational observational cohort study - Heerspink, HJ L; Karasik, A; Thuresson, M (Lancet Diabetes Endocrinol, 2020)